Cargando…

Healing, surviving, or dying? – projecting the German future disease burden using a Markov illness-death model

BACKGROUND: In view of the upcoming demographic transition, there is still no clear evidence on how increasing life expectancy will affect future disease burden, especially regarding specific diseases. In our study, we project the future development of Germany’s ten most common non-infectious diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Milan, Valeska, Fetzer, Stefan, Hagist, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799167/
https://www.ncbi.nlm.nih.gov/pubmed/33430836
http://dx.doi.org/10.1186/s12889-020-09941-6
_version_ 1783635107225010176
author Milan, Valeska
Fetzer, Stefan
Hagist, Christian
author_facet Milan, Valeska
Fetzer, Stefan
Hagist, Christian
author_sort Milan, Valeska
collection PubMed
description BACKGROUND: In view of the upcoming demographic transition, there is still no clear evidence on how increasing life expectancy will affect future disease burden, especially regarding specific diseases. In our study, we project the future development of Germany’s ten most common non-infectious diseases (arthrosis, coronary heart disease, pulmonary, bronchial and tracheal cancer, chronic obstructive pulmonary disease, cerebrovascular diseases, dementia, depression, diabetes, dorsal pain and heart failure) in a Markov illness-death model with recovery until 2060. METHODS: The disease-specific input data stem from a consistent data set of a major sickness fund covering about four million people, the demographic components from official population statistics. Using six different scenarios concerning an expansion and a compression of morbidity as well as increasing recovery and effective prevention, we can show the possible future range of disease burden and, by disentangling the effects, reveal the significant differences between the various diseases in interaction with the demographic components. RESULTS: Our results indicate that, although strongly age-related diseases like dementia or heart failure show the highest relative increase rates, diseases of the musculoskeletal system, such as dorsal pain and arthrosis, still will be responsible for the majority of the German population’s future disease burden in 2060, with about 25–27 and 13–15 million patients, respectively. Most importantly, for almost all considered diseases a significant increase in burden of disease can be expected even in case of a compression of morbidity. CONCLUSION: A massive case-load is emerging on the German health care system, which can only be alleviated by more effective prevention. Immediate action by policy makers and health care managers is needed, as otherwise the prevalence of widespread diseases will become unsustainable from a capacity point-of-view.
format Online
Article
Text
id pubmed-7799167
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77991672021-01-12 Healing, surviving, or dying? – projecting the German future disease burden using a Markov illness-death model Milan, Valeska Fetzer, Stefan Hagist, Christian BMC Public Health Research Article BACKGROUND: In view of the upcoming demographic transition, there is still no clear evidence on how increasing life expectancy will affect future disease burden, especially regarding specific diseases. In our study, we project the future development of Germany’s ten most common non-infectious diseases (arthrosis, coronary heart disease, pulmonary, bronchial and tracheal cancer, chronic obstructive pulmonary disease, cerebrovascular diseases, dementia, depression, diabetes, dorsal pain and heart failure) in a Markov illness-death model with recovery until 2060. METHODS: The disease-specific input data stem from a consistent data set of a major sickness fund covering about four million people, the demographic components from official population statistics. Using six different scenarios concerning an expansion and a compression of morbidity as well as increasing recovery and effective prevention, we can show the possible future range of disease burden and, by disentangling the effects, reveal the significant differences between the various diseases in interaction with the demographic components. RESULTS: Our results indicate that, although strongly age-related diseases like dementia or heart failure show the highest relative increase rates, diseases of the musculoskeletal system, such as dorsal pain and arthrosis, still will be responsible for the majority of the German population’s future disease burden in 2060, with about 25–27 and 13–15 million patients, respectively. Most importantly, for almost all considered diseases a significant increase in burden of disease can be expected even in case of a compression of morbidity. CONCLUSION: A massive case-load is emerging on the German health care system, which can only be alleviated by more effective prevention. Immediate action by policy makers and health care managers is needed, as otherwise the prevalence of widespread diseases will become unsustainable from a capacity point-of-view. BioMed Central 2021-01-11 /pmc/articles/PMC7799167/ /pubmed/33430836 http://dx.doi.org/10.1186/s12889-020-09941-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Milan, Valeska
Fetzer, Stefan
Hagist, Christian
Healing, surviving, or dying? – projecting the German future disease burden using a Markov illness-death model
title Healing, surviving, or dying? – projecting the German future disease burden using a Markov illness-death model
title_full Healing, surviving, or dying? – projecting the German future disease burden using a Markov illness-death model
title_fullStr Healing, surviving, or dying? – projecting the German future disease burden using a Markov illness-death model
title_full_unstemmed Healing, surviving, or dying? – projecting the German future disease burden using a Markov illness-death model
title_short Healing, surviving, or dying? – projecting the German future disease burden using a Markov illness-death model
title_sort healing, surviving, or dying? – projecting the german future disease burden using a markov illness-death model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799167/
https://www.ncbi.nlm.nih.gov/pubmed/33430836
http://dx.doi.org/10.1186/s12889-020-09941-6
work_keys_str_mv AT milanvaleska healingsurvivingordyingprojectingthegermanfuturediseaseburdenusingamarkovillnessdeathmodel
AT fetzerstefan healingsurvivingordyingprojectingthegermanfuturediseaseburdenusingamarkovillnessdeathmodel
AT hagistchristian healingsurvivingordyingprojectingthegermanfuturediseaseburdenusingamarkovillnessdeathmodel